Extracellular matrix biomarker, fibulin-1 and its association with soluble uPAR in a bi-ethnic South African population: The SAfrEIC study

Heart Lung and Circulation

Volumn 24, Issue 3, 2015, Pages 298-305

  du Plooy, Christine S ^a   Kruger, Ruan ^a   Huisman, Hugo W ^a   Rasmussen, Lars M ^b   Eugen Olsen, Jesper ^c   Schutte, Aletta E ^a  

^a NORTH WEST UNIVERSITY   (South Africa)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

African; Cardiac fibrosis; Caucasian; Fibulin 1; Inflammation; Soluble urokinase type plasminogen activator receptor

Indexed keywords

ALBUMIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; FIBULIN; FIBULIN 1; UNCLASSIFIED DRUG; UROKINASE RECEPTOR; CALCIUM BINDING PROTEIN; SERUM ALBUMIN;

ADULT; AFRICAN; ALBUMIN BLOOD LEVEL; ARTERIOSCLEROSIS; ARTICLE; BLOOD ANALYSIS; CARDIOVASCULAR DISEASE; CAUCASIAN; ETHNIC DIFFERENCE; EXTRACELLULAR MATRIX; FEMALE; HEART MUSCLE FIBROSIS; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; PRIORITY JOURNAL; PROTEIN DETERMINATION; SEX DIFFERENCE; ATHEROSCLEROSIS; BLACK PERSON; BLOOD; CLINICAL TRIAL; ETHNOLOGY; METABOLISM; MIDDLE AGED; SOUTH AFRICA;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CALCIUM-BINDING PROTEINS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; MALE; MIDDLE AGED; RECEPTORS, UROKINASE PLASMINOGEN ACTIVATOR; SERUM ALBUMIN; SOUTH AFRICA;

EID: 84923290291     PISSN: 14439506     EISSN: 14442892     Source Type: Journal    
DOI: 10.1016/j.hlc.2014.09.019     Document Type: Article

References (35)

1. van Horssen J., Dijkstra C.D., de Vries H.E. The extracellular matrix in multiple sclerosis pathology. J Neurochem 2007, 103:1293-1301.
2. Jimenez S.A., Derk E.T. Following the molecular pathways toward an understanding of the pathogenesis of systemic sclerosis. Ann Intern Med 2004, 140:37-50.
3. Bennet M.R. Apoptosis of vascular smooth muscle cells in vascular remodelling and atherosclerotic plaque rupture. Cardiovasc Res 1999, 41:361-368.
4. Kerenyi L., Mihalka L., Csiba L., Basco H., Bereczki D. Role of hyperlipidemia in atherosclerotic plaque formation in the internal carotid artery. J Clin Ultrasound 2006, 34:283-288.
5. Bouchey D., Argraves W.S., Little C.D. Fibulin-1, vitronectin and fibronectin expression during avian cardiac valve and septa development. Anat Rec 1996, 244:540-551.
6. Thuno M., Maoho B., Eugen-Olsen J. suPAR: the molecular crystal ball. Dis Markers 2009, 27:157-172.
7. Donadello K., Scolletta S., Covajes C., Vincent J. suPAR as prognostic marker in sepsis. BMC Med 2012, 10:1-9.
8. Cangemi C., Skov V., Poulsen M.K., Funder J., Twal O., Gall M.A. Fibulin-1 is a marker for arterial extracellular matrix alterations in type 2 diabetes. Clinic Chem 2011, 57:1556-1565.
9. Dahl J.S., Moller J.E., Videbaek L., Poulsen M.K., Rudbaek T.R., Pellikka P.A., et al. Plasma fibulin-1 is linked to restrictive filling of the left ventricle and to mortality in patients with aortic valve stenosis. J Am Heart Assoc 2012, 1:3889-3898.
10. Argraves W.S., Tanaka A., Smith E.P., Twal W.O., Argraves K.M., Fan D., et al. Fibulin-1 and fibrinogen in human atherosclerotic lesions. Histochem Cell Biol 2009, 132:559-565.
11. Kruger R., Schutte R., Huisman H.W., Argraves W.S., Rasmussen L.M., Olsen M.H., et al. NT-proBNP is associated with fibulin-1 in Africans: The SAfrEIC study. Atherosclerosis 2012, 222:216-221.
12. Argraves W.S., Grenne L.M., Cooley M.A., Gallaghar W.M. Fibulins: physiological and disease perspectives. EMBO Rep 2003, 4:1127-1131.
13. Kania G., Blyszczuk P., Eriksson U. Mechanisms of cardiac fibrosis in inflammatory heart disease. Trends Cardiovas Med 2009, 19:247-252.
14. Kuusisto J., Karja V., Sipola P., Kholova I., Peukkurinen K., Jaaskelainen P., et al. Low-grade inflammation and the phenotypic expression of myocardial fibrosis in hypertrophic cardiomyopathy. Heart 2012, 98:1007-1014.
15. Clarke R., Emberson J.R., Breeze E., Casas J.P., Parish S., Hingorani A.D., et al. Biomarkers of inflammation predict both vascular and non-vascular mortality in older men. Eur Heart J 2008, 29:800-809.
16. Wang Y., Chun O.K., Song W.O. Plasma and dietary antioxidant status as cardiovascular disease risk factors: A review of human studies. Nutrients 2013, 5:2969-3004.
17. Schutte A.E., Myburgh A., Olsen M.H., Eugen-Olsen J., Schutte R. Exploring soluble urokinase plasminogen activator receptor and its relationship with arterial stiffness in a bi-ethnic population: the SAfrEIC study. Thromb Res 2012, 130:273-277.
18. Kruger R., Schutte R., Huisman H.W., van Rooyen J.M., Malan N.T., Fourie C.M.T., et al. Associations between reactive oxygen species, blood pressure and arterial stiffness in black South Africans: SABPA study. J Hum Hypertens 2012, 26:91-97.
19. Schutte A.E., Huisman H.W., Schutte R., van Rooyen J.M., Malan L., Malan N.T., et al. Arterial stiffness profiles: investigating various sections of the arterial tree of African and Caucasian people. Clin Exp Hypertens 2011, 33:511-517.
20. Stewart S., Wilkinson D., Becker A., Askew D., Ntyintyane L., McMurray J.J., et al. Mapping the emergence of heart disease in a black, urban population in Africa: The Heart of Soweto Study. Int J Cardiol 2006, 108:101-108.
21. Tibazarwa K., Ntyintyane L., Sliwa K., Gemtholtz T., Carrington M., Wilkinson D., et al. A time bomb of cardiovascular risk factors in South Africa: Results from the Heart of Soweto Study "Heart Awareness Days". Int J Cardiol 2009, 132:233-239.
22. Schutte A.E., Huisman H.W., van Rooyen J.M., Malan N.T., Schutte R. Validation of the finometer device for measurement of blood pressure in black women. J Hum Hypertens 2004, 18:79-84.
23. Friedewald W.T., Levy R.I., Frederickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. J Biol Chem 1972, 18:499-502.
24. Allin K.H., Bojesen S.E., Nordestgaard B.G. Baseline C-reactive protein is associated with incident cancer and survival in patients with cancer. J Clin Oncol 2009, 27:2217-2224.
25. Chakrabarti S., Lekontseva O., Davidge S.T. Estrogen is a modulator of vascular inflammation. IUBMB Life 2008, 60:376-382.
26. Strehlow K., Rotter S., Wassmann S., Adam O., Groche C., Laufs K. Modulation of antioxidant enzyme expression and function by estrogen. Circ Res 2003, 93:170-177.
27. Fuhrman B. The urokinase system in the pathogenesis of atherosclerosis. Atherosclerosis 2012, 222:8-14.
28. Fourie C.M.T., van Rooyen J.M., Kruger A., Olsen M.H., Eugen-Olsen J., Schutte R., et al. Soluble urokinase plasminogen activator receptor is associated with metabolic changes in HIV-1-infected Africans: A prospective study. Inflammation 2012, 35:221-229.
29. Park S., Lakatta E.G. Role of inflammation in the pathogenesis of arterial stiffness. Yonsei Med J 2012, 53:258-261.
30. Lapenna D., Ciofani G., Ucchino S., Pierdomenico S.D., Cuccurullo C., Giamberardino M.A., et al. Serum albumin and biomolecular oxidative damage of human atherosclerotic plaques. Clin Biochem 2010, 43:1458-1460.
31. Menon V., Greene T., Wang X., Pereira A.A., Marcovina S.M., Becj G.J., et al. C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease. Kidney Int 2005, 68:766-772.
32. Eugen-Olsen J., Anderson O., Linneberg A., Ladelund S., Hansen T.W., Langkilde A., et al. Circulating soluble urokianse plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population. J Intern Med 2010, 268:296-308.
33. Marcovina S.M., Albers J.J., Jacobs D.R., Perkins C.E., Howard B.V., Savage P. Lipoprotein(a) concentration and apolipoprotein(a) phenotypes in Caucasians and African Americans: The CARDIA study. Arterioscler Thromb Vasc Biol 1993, 13:1037-1045.
34. Bermudez E.A., Rifai N., Buring J.E., Manson J.E., Ridker P.M. Relation between markers of systemic vascular inflammation and smoking in women. Am J Cardiol 2002, 89:1117-1119.
35. Jefferis B.J., Lawlor D.A., Ebrahim S., Wannamethee S.G., Feyerabend C., Doig M., et al. Cotinine-assessed second-hand smoke exposure and risk of cardiovascular disease in older adults. Heart 2010, 96:854-859.